nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of complement component 3 does not prevent classical pathway–mediated hemolysis
|
Zhang, Lingjun |
|
|
|
12 |
p. 1808-1814 |
artikel |
2 |
A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2
|
Tølbøll Sørensen, Anne Louise |
|
|
|
12 |
p. 2569-2574 |
artikel |
3 |
A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation
|
Okada, Masahiko |
|
|
|
12 |
p. 2631-2639 |
artikel |
4 |
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
|
Drusbosky, Leylah M. |
|
|
|
12 |
p. 1837-1847 |
artikel |
5 |
Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2 V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
|
|
|
|
|
12 |
p. 2575 |
artikel |
6 |
Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura
|
Shin, Jin-Sup |
|
|
|
12 |
p. 3792-3802 |
artikel |
7 |
American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in surgical and medical patients and long-distance travelers in Latin America
|
Neumann, Ignacio |
|
|
|
12 |
p. 3636-3649 |
artikel |
8 |
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain
|
Brandow, Amanda M. |
|
|
|
12 |
p. 2656-2701 |
artikel |
9 |
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
|
Stahl, Maximilian |
|
|
|
12 |
p. 2709-2714 |
artikel |
10 |
Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin
|
Belcher, Donald A. |
|
|
|
12 |
p. 2739-2750 |
artikel |
11 |
Approach to the diagnosis of aplastic anemia
|
DeZern, Amy E. |
|
|
|
12 |
p. 2660-2671 |
artikel |
12 |
A report of clustered COVID-19 in a hematology ward
|
Wu, Yaohui |
|
|
|
12 |
p. 2736-2738 |
artikel |
13 |
Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia
|
Bosticardo, Marita |
|
|
|
12 |
p. 2611-2616 |
artikel |
14 |
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
|
Etra, Aaron |
|
|
|
12 |
p. 3707-3715 |
artikel |
15 |
ATG4A regulates human erythroid maturation and mitochondrial clearance
|
Stolla, Massiel Chavez |
|
|
|
12 |
p. 3579-3589 |
artikel |
16 |
Autologous transplant and second malignancies in MM
|
Pasvolsky, Oren |
|
|
|
12 |
p. 2731-2732 |
artikel |
17 |
A wholesale approach to disarm multiple myeloma
|
Cenci, Simone |
|
|
|
12 |
p. 2938-2939 |
artikel |
18 |
B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency
|
Oshrine, Benjamin |
|
|
|
12 |
p. 1795-1798 |
artikel |
19 |
BCR-ABL + acute myeloid leukemia: are we always dealing with a high-risk disease?
|
Neuendorff, Nina Rosa |
|
|
|
12 |
p. 1409-1411 |
artikel |
20 |
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia
|
Olesinski, Elyse A. |
|
|
|
12 |
p. 2917-2923 |
artikel |
21 |
Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival
|
Gangat, Naseema |
|
|
|
12 |
p. 2694-2698 |
artikel |
22 |
Blood group ABO gene–encoded A transferase catalyzes the biosynthesis of FORS1 antigen of FORS system upon Met69Thr/Ser substitution
|
Cid, Emili |
|
|
|
12 |
p. 1371-1381 |
artikel |
23 |
BRAF-V600E–mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor
|
Mastropolo, Rosemarie |
|
|
|
12 |
p. 1848-1853 |
artikel |
24 |
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
|
Bonfiglio, Silvia |
|
|
|
12 |
p. 2794-2806 |
artikel |
25 |
CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages
|
Haabeth, Ole Audun W. |
|
|
|
12 |
p. 2595-2605 |
artikel |
26 |
CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells
|
Ansari, Unain |
|
|
|
12 |
p. 3626-3631 |
artikel |
27 |
Cell origin–dependent cooperativity of mutant Dnmt3a and Npm1 in clonal hematopoiesis and myeloid malignancy
|
SanMiguel, Jennifer M. |
|
|
|
12 |
p. 3666-3677 |
artikel |
28 |
Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita
|
Shukla, Siddharth |
|
|
|
12 |
p. 2717-2722 |
artikel |
29 |
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL
|
Kadri, Sabah |
|
|
|
12 |
p. 715-727 |
artikel |
30 |
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
|
Akahoshi, Yu |
|
|
|
12 |
p. 2699-2708 |
artikel |
31 |
Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance
|
Clay-Gilmour, Alyssa I. |
|
|
|
12 |
p. 2789-2797 |
artikel |
32 |
Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function
|
Leung, Isabel |
|
|
|
12 |
p. 2718-2730 |
artikel |
33 |
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
|
Li, Maggie |
|
|
|
12 |
p. 3678-3683 |
artikel |
34 |
Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
|
Moujalled, Donia M. |
|
|
|
12 |
p. 2762-2767 |
artikel |
35 |
COVID-19 coagulopathy vs disseminated intravascular coagulation
|
Levi, Marcel |
|
|
|
12 |
p. 2850 |
artikel |
36 |
CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK+ lymphoma after transplantation
|
Rajan, Soumya Sundara |
|
|
|
12 |
p. 1788-1794 |
artikel |
37 |
Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis
|
Caron, François |
|
|
|
12 |
p. 772-778 |
artikel |
38 |
CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study
|
O'Dwyer, M. |
|
|
|
12 |
p. 1815-1825 |
artikel |
39 |
Defenestrated endothelium delays liver-directed gene transfer in hemophilia A mice
|
Kaminski, Tomasz W. |
|
|
|
12 |
p. 3729-3734 |
artikel |
40 |
Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
|
Hill, Quentin A. |
|
|
|
12 |
p. 1897-1906 |
artikel |
41 |
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study
|
Stojkov, Igor |
|
|
|
12 |
p. 2772-2783 |
artikel |
42 |
Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency
|
Bifsha, Panojot |
|
|
|
12 |
p. 2606-2610 |
artikel |
43 |
Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma
|
Spaan, Ingrid |
|
|
|
12 |
p. 2593-2607 |
artikel |
44 |
Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice
|
Xiao, Pingnan |
|
|
|
12 |
p. 1480-1494 |
artikel |
45 |
Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects
|
Li, Shirong |
|
|
|
12 |
p. 2926-2937 |
artikel |
46 |
Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
|
Takiar, Radhika |
|
|
|
12 |
p. 2912-2916 |
artikel |
47 |
Editorial Board
|
|
|
|
|
12 |
p. i |
artikel |
48 |
Editorial Board
|
|
|
|
|
12 |
p. i |
artikel |
49 |
Editorial Board
|
|
|
|
|
12 |
p. i |
artikel |
50 |
Editorial Board
|
|
|
|
|
12 |
p. i |
artikel |
51 |
Editorial Board
|
|
|
|
|
12 |
p. i |
artikel |
52 |
Editorial Board
|
|
|
|
|
12 |
p. i |
artikel |
53 |
Editorial Board
|
|
|
|
|
12 |
p. i |
artikel |
54 |
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma
|
Roddie, Claire |
|
|
|
12 |
p. 2872-2883 |
artikel |
55 |
External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation
|
Shouval, Roni |
|
|
|
12 |
p. 1881-1890 |
artikel |
56 |
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms
|
Spinner, Michael A. |
|
|
|
12 |
p. 2768-2778 |
artikel |
57 |
Fabrizio VA, Boelens JJ, Mauguen A, et al. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022;6(7):1961-1968.
|
|
|
|
|
12 |
p. 2924 |
artikel |
58 |
Fertility testing knowledge and attitudes in male adolescents and young adults with SCD and their caregivers: a pilot study
|
Nahata, Leena |
|
|
|
12 |
p. 3703-3706 |
artikel |
59 |
First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis
|
Vener, Claudia |
|
|
|
12 |
p. 2723-2735 |
artikel |
60 |
Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders
|
Gadoury-Levesque, Vanessa |
|
|
|
12 |
p. 2578-2594 |
artikel |
61 |
Front Matter
|
|
|
|
|
12 |
p. ii |
artikel |
62 |
Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder
|
Niaz, Aram |
|
|
|
12 |
p. 3779-3791 |
artikel |
63 |
Further analysis of incidence of multiple myeloma among atomic-bomb survivors, 1950 to 1994
|
Yoshida, Noriaki |
|
|
|
12 |
p. 2807-2810 |
artikel |
64 |
Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101
|
Ritchie, Ellen K. |
|
|
|
12 |
p. 3812-3820 |
artikel |
65 |
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes
|
Olin, Rebecca L. |
|
|
|
12 |
p. 2810-2820 |
artikel |
66 |
Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A
|
Tarrant, Julie |
|
|
|
12 |
p. 2644-2655 |
artikel |
67 |
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning
|
van Besien, Koen |
|
|
|
12 |
p. 1858-1867 |
artikel |
68 |
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
|
Lai, Tzung-Huei |
|
|
|
12 |
p. 2897-2911 |
artikel |
69 |
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
|
Durot, Eric |
|
|
|
12 |
p. 3655-3658 |
artikel |
70 |
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
|
McNerney, Kevin O. |
|
|
|
12 |
p. 2758-2771 |
artikel |
71 |
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia
|
Renou, Laurent |
|
|
|
12 |
p. 733-747 |
artikel |
72 |
HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh
|
Chandrakasan, Shanmuganathan |
|
|
|
12 |
p. 3751-3755 |
artikel |
73 |
Hurdles in treating Hurler disease: potential routes to achieve a “real” cure
|
van den Broek, Brigitte T.A. |
|
|
|
12 |
p. 2837-2849 |
artikel |
74 |
IFNγ regulates NAD+ metabolism to promote the respiratory burst in human monocytes
|
McCann, Katelyn J. |
|
|
|
12 |
p. 3821-3834 |
artikel |
75 |
Ilett EE, Jørgensen M, Noguera-Julian M, et al. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv. 2020;4(22):5797-5809.
|
|
|
|
|
12 |
p. 2677 |
artikel |
76 |
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML
|
Perriello, Vincenzo Maria |
|
|
|
12 |
p. 2855-2871 |
artikel |
77 |
Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
|
Ragon, Brittany Knick |
|
|
|
12 |
p. 2746-2757 |
artikel |
78 |
Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations
|
Shimonishi, Naruto |
|
|
|
12 |
p. 2831-2842 |
artikel |
79 |
Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014
|
Carpenter, Shannon L. |
|
|
|
12 |
p. 1403-1408 |
artikel |
80 |
Inflammasome activation promotes venous thrombosis through pyroptosis
|
Zhang, Yan |
|
|
|
12 |
p. 2619-2623 |
artikel |
81 |
Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia
|
Chartomatsidou, Elisavet |
|
|
|
12 |
p. 1891-1896 |
artikel |
82 |
Interaction between maternal killer immunoglobulin-like receptors and offspring HLAs and susceptibility of childhood ALL
|
Feng, Qianxi |
|
|
|
12 |
p. 3756-3766 |
artikel |
83 |
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma
|
Nath, Karthik |
|
|
|
12 |
p. 2644-2649 |
artikel |
84 |
In vivo dynamics of human hematopoietic stem cells: novel concepts and future directions
|
Scala, Serena |
|
|
|
12 |
p. 1916-1924 |
artikel |
85 |
KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure
|
Armand, Philippe |
|
|
|
12 |
p. 2617-2622 |
artikel |
86 |
Koh J, Jang I, Mun S, et al. Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Adv. 2021;5(20):3919-3930.
|
|
|
|
|
12 |
p. 3659-3660 |
artikel |
87 |
Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.
|
|
|
|
|
12 |
p. 2925 |
artikel |
88 |
Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis
|
Kalot, Mohamad A. |
|
|
|
12 |
p. 3735-3745 |
artikel |
89 |
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice
|
Ingoglia, Giada |
|
|
|
12 |
p. 2751-2761 |
artikel |
90 |
Lissitchkov T, Willemze A, Katragadda S, et al. Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study. Blood Adv. 2022;6(4):1089-1094.
|
|
|
|
|
12 |
p. 3625 |
artikel |
91 |
Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis
|
Laroche, Audree |
|
|
|
12 |
p. 3697-3702 |
artikel |
92 |
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
|
Coutre, Steven E. |
|
|
|
12 |
p. 1799-1807 |
artikel |
93 |
Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients
|
Vulliamy, Paul |
|
|
|
12 |
p. 2623-2630 |
artikel |
94 |
Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation
|
Li, Ang |
|
|
|
12 |
p. 707-714 |
artikel |
95 |
Managing patients who are receiving warfarin or a direct oral anticoagulant and need an elective surgery or procedure
|
Douketis, James |
|
|
|
12 |
p. 1925 |
artikel |
96 |
Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage
|
Uter, Stacey |
|
|
|
12 |
p. 2586-2592 |
artikel |
97 |
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
|
Pollard, Jessica A. |
|
|
|
12 |
p. 3803-3811 |
artikel |
98 |
More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura
|
Picod, Adrien |
|
|
|
12 |
p. 2678-2680 |
artikel |
99 |
MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods
|
Roshal, Mikhail |
|
|
|
12 |
p. 728-732 |
artikel |
100 |
Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review
|
Rhee, John Y. |
|
|
|
12 |
p. 1854-1857 |
artikel |
101 |
NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation
|
Hogan, Louise E. |
|
|
|
12 |
p. 1412-1416 |
artikel |
102 |
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
|
Rashidi, Armin |
|
|
|
12 |
p. 1826-1836 |
artikel |
103 |
Papaioannou D, Volinia S, Nicolet D, et al. Clinical and functional significance of circular RNAs in cytogenetically normal AML. Blood Adv. 2020;4(2):239-251.
|
|
|
|
|
12 |
p. 2577 |
artikel |
104 |
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
|
Bezman, Natalie A. |
|
|
|
12 |
p. 753-765 |
artikel |
105 |
Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL
|
Zurko, Joanna |
|
|
|
12 |
p. 2657-2669 |
artikel |
106 |
Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism
|
Yepes-Nuñez, Juan José |
|
|
|
12 |
p. 2798-2809 |
artikel |
107 |
Physiologically based serum ferritin thresholds for iron deficiency in women of reproductive age who are blood donors
|
Addo, O. Yaw |
|
|
|
12 |
p. 3661-3665 |
artikel |
108 |
Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy
|
Lee, Brittany M. |
|
|
|
12 |
p. 2825-2830 |
artikel |
109 |
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells
|
Puhm, Florian |
|
|
|
12 |
p. 3593-3605 |
artikel |
110 |
Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice
|
Fan, Xuemei |
|
|
|
12 |
p. 1439-1448 |
artikel |
111 |
Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor
|
Politikos, Ioannis |
|
|
|
12 |
p. 1367-1370 |
artikel |
112 |
Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant
|
Al Malki, Monzr M. |
|
|
|
12 |
p. 2650-2659 |
artikel |
113 |
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data
|
Parviz, Mehdi |
|
|
|
12 |
p. 3716-3728 |
artikel |
114 |
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method
|
Vachon, Celine M. |
|
|
|
12 |
p. 3746-3750 |
artikel |
115 |
Prevalence of IGLV3-21R110 among familial CLL: a retrospective study of 45 cases
|
Armand, Marine |
|
|
|
12 |
p. 3632-3635 |
artikel |
116 |
Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy
|
Vick, Eric J. |
|
|
|
12 |
p. 779-791 |
artikel |
117 |
Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets
|
Casari, Caterina |
|
|
|
12 |
p. 1417-1428 |
artikel |
118 |
Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations
|
Andolfo, Immacolata |
|
|
|
12 |
p. 2681-2693 |
artikel |
119 |
Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
|
|
|
|
|
12 |
p. 2576 |
artikel |
120 |
Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α
|
Macchi, Beatrice |
|
|
|
12 |
p. 748-752 |
artikel |
121 |
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma
|
Peres, Lauren C. |
|
|
|
12 |
p. 3767-3778 |
artikel |
122 |
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
|
Iacoboni, Gloria |
|
|
|
12 |
p. 3606-3610 |
artikel |
123 |
Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome
|
Katzerke, Christiane |
|
|
|
12 |
p. 2811-2824 |
artikel |
124 |
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001
|
Vrooman, Lynda M. |
|
|
|
12 |
p. 1449-1458 |
artikel |
125 |
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment
|
Darzi, Andrea J. |
|
|
|
12 |
p. 2557-2566 |
artikel |
126 |
Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report
|
Johnston, Emily E. |
|
|
|
12 |
p. 2843-2854 |
artikel |
127 |
Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling
|
Wu, Vernon |
|
|
|
12 |
p. 1470-1479 |
artikel |
128 |
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study
|
Ageno, Walter |
|
|
|
12 |
p. 3569-3578 |
artikel |
129 |
Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
|
Petersdorf, Effie W. |
|
|
|
12 |
p. 2888-2896 |
artikel |
130 |
Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice
|
Neunert, Cindy E. |
|
|
|
12 |
p. 1907-1915 |
artikel |
131 |
Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency
|
Wu, Zhijie |
|
|
|
12 |
p. 2702-2716 |
artikel |
132 |
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
|
Allen, Pamela B. |
|
|
|
12 |
p. 2670-2676 |
artikel |
133 |
Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes
|
Ali, Abdullah Mahmood |
|
|
|
12 |
p. 1393-1402 |
artikel |
134 |
Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden
|
Karantanos, Theodoros |
|
|
|
12 |
p. 2567-2576 |
artikel |
135 |
Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma
|
Gardner, Andrea |
|
|
|
12 |
p. 3650-3654 |
artikel |
136 |
Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL
|
Wölfl, Matthias |
|
|
|
12 |
p. 1382-1385 |
artikel |
137 |
Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis
|
Patel, Payal |
|
|
|
12 |
p. 2779-2788 |
artikel |
138 |
The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia
|
Kumar, Rahul |
|
|
|
12 |
p. 3611-3624 |
artikel |
139 |
The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective
|
George, James N. |
|
|
|
12 |
p. 1510-1516 |
artikel |
140 |
The use of defibrotide in blood and marrow transplantation
|
Richardson, Paul G. |
|
|
|
12 |
p. 1495-1509 |
artikel |
141 |
TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation
|
Shrimpton, Jennifer |
|
|
|
12 |
p. 2821-2836 |
artikel |
142 |
Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma
|
Dahi, Parastoo B. |
|
|
|
12 |
p. 2608-2618 |
artikel |
143 |
Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression
|
Manson, Megan A. |
|
|
|
12 |
p. 3557-3568 |
artikel |
144 |
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
|
Sarhan, Dhifaf |
|
|
|
12 |
p. 1459-1469 |
artikel |
145 |
TTMV-RARA fusion as a recurrent cause of AML with APL characteristics
|
Sala-Torra, Olga |
|
|
|
12 |
p. 3590-3592 |
artikel |
146 |
Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate
|
Zannoni, Johanna |
|
|
|
12 |
p. 1868-1880 |
artikel |
147 |
Unraveling the pathophysiology of lower-limb postthrombotic syndrome in adolescents: a proof-of-concept study
|
Avila, M. Laura |
|
|
|
12 |
p. 2784-2793 |
artikel |
148 |
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
|
Berdel, Andrew F. |
|
|
|
12 |
p. 3684-3696 |
artikel |
149 |
Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993.
|
|
|
|
|
12 |
p. 2715-2717 |
artikel |
150 |
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
|
Vijenthira, Abi |
|
|
|
12 |
p. 2624-2643 |
artikel |
151 |
Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID)
|
Drott, Kristina |
|
|
|
12 |
p. 1386-1392 |
artikel |
152 |
Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
|
Zhang, Shijia |
|
|
|
12 |
p. 2640-2643 |
artikel |
153 |
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells
|
Teh, Charis E. |
|
|
|
12 |
p. 2733-2745 |
artikel |
154 |
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis
|
Yamshon, Samuel |
|
|
|
12 |
p. 1429-1438 |
artikel |
155 |
Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome
|
Sun, Chunyan |
|
|
|
12 |
p. 2563-2568 |
artikel |
156 |
X-ray crystal structure of plasmin with tranexamic acid–derived active site inhibitors
|
Law, Ruby H.P. |
|
|
|
12 |
p. 766-771 |
artikel |
157 |
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma
|
Tam, Constantine S. |
|
|
|
12 |
p. 2577-2585 |
artikel |
158 |
Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia
|
Tam, Constantine S. |
|
|
|
12 |
p. 2884-2887 |
artikel |